Marine probiotics: increasing coral resistance to bleaching through microbiome manipulation

Although the early coral reef-bleaching warning system (NOAA/USA) is established, there is no feasible treatment that can minimize temperature bleaching and/or disease impacts on corals in the field. Here, we present the first attempts to extrapolate the widespread and well-established use of bacterial consortia to protect or improve health in other organisms (e.g., humans and plants) to corals. Manipulation of the coral-associated microbiome was facilitated through addition of a consortium of native (isolated from Pocillopora damicornis and surrounding seawater) putatively beneficial microorganisms for corals (pBMCs), including five Pseudoalteromonas sp., a Halomonas taeanensis and a Cobetia marina-related species strains. The results from a controlled aquarium experiment in two temperature regimes (26 °C and 30 °C) and four treatments (pBMC; pBMC with pathogen challenge – Vibrio coralliilyticus, VC; pathogen challenge, VC; and control) revealed the ability of the pBMC consortium to partially mitigate coral bleaching. Significantly reduced coral-bleaching metrics were observed in pBMC-inoculated corals, in contrast to controls without pBMC addition, especially challenged corals, which displayed strong bleaching signs as indicated by significantly lower photopigment contents and Fv/Fm ratios. The structure of the coral microbiome community also differed between treatments and specific bioindicators were correlated with corals inoculated with pBMC (e.g., Cobetia sp.) or VC (e.g., Ruegeria sp.). Our results indicate that the microbiome in corals can be manipulated to lessen the effect of bleaching, thus helping to alleviate pathogen and temperature stresses, with the addition of BMCs representing a promising novel approach for minimizing coral mortality in the face of increasing environmental impacts

Chemical composition of 8 <it>eucalyptus</it> species' essential oils and the evaluation of their antibacterial, antifungal and antiviral activities

<p>Abstract</p> <p>Background</p> <p>In 1957, Tunisia introduced 117 species of <it>Eucalyptus</it>; they have been used as fire wood, for the production of mine wood and to fight erosion. Actually, <it>Eucalyptus</it> essential oil is traditionally used to treat respiratory tract disorders such as pharyngitis, bronchitis, and sinusitis. A few investigations were reported on the biological activities of <it>Eucalyptus</it> oils worldwide. In Tunisia, our previous works conducted in 2010 and 2011 had been the first reports to study the antibacterial activities against reference strains. At that time it was not possible to evaluate their antimicrobial activities against clinical bacterial strains and other pathogens such as virus and fungi.</p> <p>Methods</p> <p>The essential oils of eight <it>Eucalyptus</it> species harvested from the Jbel Abderrahman, Korbous (North East Tunisia) and Souinet arboreta (North of Tunisia) were evaluated for their antimicrobial activities by disc diffusion and microbroth dilution methods against seven bacterial isolates: <it>Haemophilus influenzae</it>, <it>Klebsiella pneumoniae</it>, <it>Pseudomonas aeruginosa</it>, <it>Staphylococcus aureus</it>, <it>Streptococcus agalactiae</it>, <it>Streptococcus pneumoniae</it> and <it>Streptococcus pyogenes</it>. In addition, the bactericidal, fungicidal and the antiviral activities of the tested oils were carried out.</p> <p>Results</p> <p>Twenty five components were identified by GC/FID and GC/MS. These components were used to correlate with the biological activities of the tested oils. The chemical principal component analysis identified three groups, each of them constituted a chemotype. According to the values of zone diameter and percentage of the inhibition (zdi, % I, respectively), four groups and subgroups of bacterial strains and three groups of fungal strains were characterized by their sensitivity levels to <it>Eucalyptus</it> oils. The cytotoxic effect and the antiviral activity varied significantly within <it>Eucalyptus</it> species oils.</p> <p>Conclusions</p> <p><it>E. odorata</it> showed the strongest activity against <it>S. aureus</it>, <it>H. influenzae</it>, <it>S. agalactiae</it>, <it>S. pyogenes</it>, <it>S. pneumoniae</it> and against all the tested fungal strains. In addition, <it>E. odorata</it> oil showed the most cytotoxic effect. However, the best antiviral activity appeared with <it>E. bicostata</it>. Virus pretreatment with <it>E. bicostata</it> essential oil showed better antiviral activity (IC₅₀ = 0.7 mg/ml, SI = 22.8) than cell-pretreatment (IC₅₀ = 4.8 mg/ml, SI = 3.33). The essential oil of <it>E. astringens</it> showed antiviral activity only when incubated with virus prior to cell infection. This activity was dose-dependent and the antiviral activity diminished with the decreasing essential oil concentration.</p